Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes

Regulatory Peptides

Volumn 142, Issue 1-2, 2007, Pages 16-23

  Chen, Zhi xin ^a,b   Chang, Min ^a   Peng, Ya li ^a   Zhao, Li ^a   Zhan, Yu rui ^a   Wang, Li jing ^a   Wang, Rui ^a,c  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c Key Laboratory of Preclinical Study for New Drugs of Gansu Province   (China)

Author keywords

Adipocyte; Differentiation; MSC; OGP(10 14); Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH FACTOR; MESSENGER RNA; OSTEOGENIC GROWTH PEPTIDE[10-14]; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

ADIPOCYTES; ADIPOGENESIS; ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ENDORPHINS; FEMALE; GENE EXPRESSION; MESENCHYMAL STEM CELLS; MICE; MICROSCOPY, PHASE-CONTRAST; NIH 3T3 CELLS; OSTEOBLASTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 34248591018     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.01.003     Document Type: Article

References (48)

1. Gimble J.M., Robinson C.E., Wu X., and Kelly K.A. The function of adipocytes in the bone marrow stroma: an update. Bone 19 (1996) 421-428
2. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., and Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102 (1992) 341-351
3. Gimble J.M., Robinson C.E., Wu X., Kelly K.A., Rodriguez B.R., Kliewer S.A., Lehmann J.M., and Morris D.C. Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50 (1996) 1087-1094
4. Dorheim M.-.A., Sullivan M., Dandapani V., Wu X., Hudson J., Segarini P.R., Rosen D.M., Aulthouse A.L., and Gimble J.M. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J Cell Physiol 154 (1993) 317-328
5. Martin R.B., Chow B.D., and Lucas P.A. Bone marrow fat content in relation to bone remodeling and serum chemistry in intact and ovariectomized dogs. Calcif Tissue Int 46 (1990) 189-194
6. Dang Z.C., Van Bezooijen R.L., Karperien M., Papapoulos S.E., and Löwik C.W.G.M. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17 (2002) 394-405
7. Okazaki R., Inoue D., Shibata M., Saika M., Kido S., Ooka H., Tomiyama H., Sakamoto Y., and Matsumoto T. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER)α or β. Endocrinology 143 (2002) 2349-2356
8. Chan G.K., Miao D., Deckelbaum R., Bolivar I., Karaplis A., and Goltzman D. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T1/2 mesenchymal cells. Endocrinology 144 (2003) 5511-5520
9. Nuttall M.E., and Gimble J.M. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone 27 (2000) 177-184
10. Bab I., Gazit D., Chorev M., Muhlrad A., Shteyer A., Greenberg Z., Namdar M., and Kahn A. Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J 11 (1992) 1867-1873
11. Bab I., Smith E., Gavish H., Namdar-Attar M., Chorev M., Chen Y., Muhlrad A., Birnbaum M.J., Stein G., and Frenkel B. Biosynthesis of osteogenic growth peptide via alternative translational initiation at AUG85 of histone H4 mRNA. J Biol Chem 274 (1999) 14474-14481
12. Greenberg Z., Chorev M., Muhlrad A., Shteyer A., Namdar-Attar M., Mansur N., and Bab I. Mitogenic action of osteogenic growth peptide (OGP): role of amino and carboxy terminal regions and charge. Biochim Biophys Acta 1178 (1993) 273-280
13. Greenberg Z., Chorev M., Muhlrad A., Shteyer A., Namdar-Attar M., Casap N., Tartakovsky A., Vidson M., and Bab I. Structural and functional characterization of osteogenic growth peptide (OGP) from human serum: identity with rat and mouse homologues. J Clin Endocrinol Metab 80 (1995) 2330-2335
14. Gavish H., Bab I., Tartakovsky A., Chorev M., Mansur N., Greenberg Z., Namdar-Attar M., and Muhlard A. Human α 2-macroglobulin is an osteogenic growth peptide binding protein. Biochemistry 36 (1997) 14883-14888
15. Greenberg Z., Gavish H., Muhlrad A., Chorev M., Shteyer A., Namdar-Attar M., Tartakovsky A., and Bab I. Isolation of osteogenic growth peptide from osteoblastic MC3T3 E1 cell cultures and demonstration of osteogenic growth peptide binding proteins. J Cell Biochem 65 (1997) 359-367
16. Bab I., Gavish H., Namdar-Attar M., Muhlrad A., Greenberg Z., Chen Y., Mansur N., Shteyer A., and Chorev M. Isolation of mitogenically active C-terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cells. J Pept Res 54 (1999) 408-414
17. Chen Y.-C., Bab I., Mansur N., Muhlrad A., Shteyer A., Namdar-Attar M., Gavish H., Vidson M., and Chorev M. Structure-bioactivity of C-terminal truncated pentapeptide of osteogenic growth peptide [OGP(10-14)]. J Pept Res 56 (2000) 147-156
18. Gabarin N., Gavish H., Muhlrad A., Chen Y., Namdar-Attar M., Nissenson R.A., Chorev M., and Bab I. Mitogenic Gi protein-MAP kinase signaling cascade in MC3T3 E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP. J Cell Biochem 81 (2001) 594-603
19. Miguel S.M., Namdar-Attar M., Noh T., Frenkel B., and Bab I. ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J Biol Chem 280 (2005) 37495-37502
20. Chen Y.-C., Muhlrad A., Shteyer A., Vidson M., Bab I., and Chorev M. Bioactive pseudopeptidic analogs and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14). J Med Chem 45 (2002) 1624-1632
21. Sun Y.Q., and Ashhurst D.E. Osteogenic growth peptide enhances the rate of fracture healing in rabbits. Cell Biol Int 22 (1998) 313-319
22. Brager M.A., Patterson M.J., Connolly J.F., and Nevo Z. Osteogenic growth peptide normally stimulated by blood loss and marrow ablation has local and systemic effects on fracture healing in rats. J Orthop Res 18 (2000) 133-139
23. Gabet Y., Müller R., Regev E., Sela J., Shteyer A., Salisbury K., Chorev M., and Bab I. Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone 35 (2004) 65-73
24. Smith E., Myerrose T.E., Kohler T., Namdar-Attar M., Bab N., Lahat O., Noh T., Li J., Chen T.T., Nolta J.A., Müller R., Bab I., and Frenkel B. Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Res 33 (2005) 1298-1308
25. Robinson D., Bab I., and Nevo Z. Osteogenic growth peptide (OGP) regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J Bone Miner Res 10 (1995) 690-696
26. Atherton E., and Sheppard R.C. Solid-phase peptide synthesis: a practical approach (1989), IRL Press, Oxford, England
27. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47 (1987) 936-942
28. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
29. Imre R., and Fekete P. A rapid technique for alkaline phosphatase enzyme activity in tissues. Acta Histochem 73 (1983) 17-21
30. Bharagava U., Bar-Lev M., Bellows C.G., and Aubin J.E. Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9 (1986) 155-163
31. Gimble J.M., Dorheim M.A., Cheng Q., Medina K., Jones R., Koren E., Piettrangeli C., and Kincade P.W. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: biochemical and molecular characterization. Eur J Immunol 20 (1990) 379-387
32. Fleet J.C., and Hock J.M. Identification of osteocalcin mRNA in non-osteoid tissue of rats and humans by reverse transcription-polymerase chain reaction. J Bone Miner Res 9 (1994) 1565-1573
33. Ahdjoudj S., Lasmoles F., Holy X., Zerath E., and Marie P.J. Transforming growth factor β2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. J Bone Miner Res 17 (2002) 668-677
34. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., and Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4 (1998) 415-428
35. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.M., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
36. Rickard D.J., Sullivan T.A., Shenker B.J., Leboy P.S., and Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161 (1994) 218-228
37. 3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139 (1998) 2622-2628
38. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., Rosen V., Mundy G.R., and Harris S.E. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142 (1998) 295-305
39. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 90 (1993) 5889-5892
40. Hauner H., Rohrig K., and Petruschke Y. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function. Eur J Clin Invest 25 (1995) 90-96
41. Takahashi Y., Okimura Y., Mizuno I., Iida K., Takahashi T., Kaji H., Abe H., and Chihara K. Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells. J Biol Chem 272 (1997) 12897-12900
42. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
43. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8 (1994) 1224-1234
44. Meunier P., Aaron J., Edouard C., and Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop 80 (1971) 147-154
45. Bellows C.G., Wang Y.H., Heersche J.N., and Aubin J.E. 1,25-dihydroxy vitamin D3 stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: comparison with the effects of dexamethasone. Endocrinology 134 (1994) 2221-2229
46. Gimble J.M., Dorheim M.A., Cheng Q., Pekala P., Enerback S., Ellingsworth L., Kincade P.W., and Wang C.S. Response of bone marrow stromal cells to adipogenic antagonists. Mol Cell Biol 57 (1989) 4587-4595
47. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., and Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
48. Garrett I.R., Chen D., Gutierrez G., Zhao M., Escobedo A., Rossini G., Harris S.E., Gallwitz W., Kim K.B., Hu S., Crews C.M., and Mundy G.R. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest 111 (2003) 1771-1782